Veracyte EVP, general counsel Annie McGuire sells over $140,000 in stock

Annie McGuire, Executive Vice President and General Counsel at Veracyte, Inc., sold a total of $140,212 worth of the company's common stock, according to a Securities and Exchange Commission filing. The stock price has increased by 31% over the past year, currently trading at $42.53. On September 4, 2026, McGuire executed two separate sales of 2,154 and 1,100 shares respectively, at prices between $42.49 and $43.38, and between $43.50 and $44.16 per share.

These transactions followed a Rule 10b5-1 trading plan she established on August 29, 2025. Veracyte's P/E ratio is 30.67, marking it as slightly overvalued according to InvestingPro Fair Value analysis. Additionally, 3,215 shares valued at $44.88 each were withheld for tax obligations related to restricted stock units. As a result, McGuire now owns 131,160 shares of Veracyte common stock, including 389 shares acquired through the company's Employee Stock Purchase Plan.

Veracyte recently reported strong second-quarter 2026 results, surpassing expectations with adjusted earnings of $0.54 per share and revenue of $150.3 million. This performance has led to increased price targets from analysts Freedom Capital and Needham, while Canaccord lowered its target due to caution regarding future revenue and earnings per share.